Rifampicin nanocrystal: towards improved antituberculosis therapy (2016)
Melo, Katherine Jasmine Curo; Ferraz, Humberto Gomes 
; Bou-Chacra, Nadia Araci
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Katherine Jasmine Curo e FERRAZ, Humberto Gomes e BOU-CHACRA, Nadia Araci. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2016APA
Melo, K. J. C., Ferraz, H. G., & Bou-Chacra, N. A. (2016). Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Melo KJC, Ferraz HG, Bou-Chacra NA. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 44 res. FCF083.[citado 2024 nov. 11 ]Vancouver
Melo KJC, Ferraz HG, Bou-Chacra NA. Rifampicin nanocrystal: towards improved antituberculosis therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 44 res. FCF083.[citado 2024 nov. 11 ]
